1Girardin F. Membrane transporter proteins: a challenge for CNS drug development[J]. Dialogues Clin Neurosci, 2006, 8 (3) :311-321.
2Ito K, Uchida Y, Ohtsuki S, et al. Quantitative membrane protein expression at the blood-brain barrier of adult and younger cynomolgus monkeys. LID-10. 1002/jps. 22487 [doi]. J Pharm Sei, 2011.
3Guo Z, Zhu J, Zhao L, et al. Expression and clinical significance of multidrug resistance proteins in brain tumors[J]. J Exp Clin Cancer Res, 2010,29:122.
4Potschka H. Targeting the brain-surmounting or bypassing the blood-brain barrier[J]. Handb Exp Pharmacol, 2010, (197) : 411-431.
5Leslie EM, Deeley RG, Cole SP. Multidrug resistance proteins., role of P-glyeoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense[J]. Toxicol Appl Pharrnacol, 2005,204 (3) :216-237.
6Urquhart BL, Kim RB. Blood-brain barrier transporters and response to CNS-active drugs[J]. Eur J Clin Pharmacol, 2009, 65 ( 11 ) : 1063-1070.
7Kirschbaum KM, Uhr M, Holthoewer D, et al. Pharmacokinetics of acute and sub chronic aripiprazole in P-glyeoprotein deficient mice[J].Neuropharmacology, 2010,59(6) :474-479.
8SarginsonJE, Lazzeroni LC, Ryan HS, et al. ABCB1 (MDR1) polymorphisms and antidepressant response in geriatric depression[J]. Pharmacogenet Genomics, 2010,20(8):467- 475.
9Iqbal M, Gibb W, Matthews SG. Cortieosteroid Regulation of P-Glyeoprotein in the Developing Blood-Brain Barrier[J]. Endocrinology, 2011,152 : 1067-1079.
10Hartz AM, Mahringer A, Miller DS, etal. 17-beta-Estradiol: a powerful modulator of blood-brain barrier BCRP activity[J]. J Cereb Blood Flow Metab, 2010,30(10):1742-1755.
同被引文献24
1Sveinsson 0 A, Kjartansson O, Valdimarsson E M.Cerebral ischemia/infarction-epidemiology, causes and symptoms[ J]. Laeknabladid ,2014,100(5 ) :271-275.
2Borst P, Schinkel A H. P-glycoprotein ABCBI:a major player in drug handling by mammals[ J ]. J Clin Invest, 2013,123(10) :4131-4136.
3Yano K, Takimoto S, Motegi T, et al. Role of P- glycoprotein in regulating cilnidipine distribution to intact and ischemic brain[J]. Drug Metab Pharmacokinet,2014,29 ( 3 ) :254-258.
4Tsai M J, Tsai S K, Hu B R, et al. Recovery of neurological function of ischemic stroke by application of conditioned medium of bone marrow mesenchymal stem cells derived from normal and cerebral ischemia rats [J]. J Biomed Sci,2014,21 (5) :2-7.
5Longa E Z, Weinstein P R, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats[ J]. Stroke, 1989,20( 1 ) :84-90.
6Kitagawa K, Matsumoto M, Tagaya M, et al. ' Ischemic tolerance'phenomenon found in the brain [ J ]. Brain Res, 1990,528( 1 ) :21-25.
7Huls M, Russel F G, Masereeuw R. The role of ATP binding cassette transporters in tissue defense and organ regeneration[ J]. J Pharmacol Exp Ther,2009,328 ( 1 ) : 3-8.
8Ktinig J, MUller F, Fromm M F. Transporters and drug- drug interactions: important determinants of drug disposition and effects [ J ]. Pharmacol Rev, 2013,65 ( 3 ) :944-950.
9Li J,Jaimes K F,Aller S G. Refined structures of mouse P-glycoprotein [ J]. Protein Sci ,2014,23 ( 1 ) :34-37.
10Cardoso F L,Brites D, Brito M A. Looking at the blood- brain barrier: molecular anatomy and possible investigation approaches [ J ]. Brain Res Rev, 2010,64 (2) :328-332.
